Sai Life Sciences Ltd commences commercial operation of 2nd phase in Bidar

Sai Life Sciences Limited has successfully commenced commercial operation of the second phase of the production block with ≈91 kL of capacity at its facility in Bidar, Karnataka, India ("Unit IV Bidar Facility") on 19th June 2025.

This is the second and final phase of the overall capacity addition of ≈195 kL which was under construction at Unit IV Bidar Facility as disclosed in the prospectus. Accordingly, the combined capacity of Unit IV Bidar Facility will be ≈640 kL which will be equipped to supply Registered Starting Materials ("RSM"), intermediates, and Active Pharmaceutical Ingredients ("APIs") for both clinical and commercial purposes.

Shares of Sai Life Sciences Limited was last trading in BSE at Rs. 765.85 as compared to the previous close of Rs. 729.20. The total number of shares traded during the day was 21047499 in over 12521 trades.

The stock hit an intraday high of Rs. 793.35 and intraday low of 720.35. The net turnover during the day was Rs. 15201610218.00.

Source : Equity Bulls

Keywords

SaiLifeSciences Pharmaceuticals INE570L01029 CommercialOperation 2ndPhase ProductionBlock Bidar Karnataka